RxDoctor Payments Data

Jennifer Tang, MD

MOHS-Micrographic Surgery · Miami, FLNPI 1740556364

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,427 of the $16,521 with a category attached, or 69.2%. 12 manufacturers reported payments, led by Regeneron at 48.3% of the total. Reporting peaked in 2019 at $8,708 and has fallen 94.1% since, to $516 in 2025. Among mohs-micrographic surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,521in general payments, 2019–2025

Across 42 payments — averaging $393.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$8K
  • Sanofi$4K
  • Sun Pharmaceutical Industries Inc.$2K
  • Galderma Laboratories, L.p.$645
  • Almirall LLC$600
  • Dermavant Sciences, Inc.$378
  • plus $1K from 6 others

What the payments were for

  • Consulting fees$11,42769%
  • Travel & lodging$1,0156%
  • Food & beverage$4,07925%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,521 in reported general payments places this provider in the 90th percentile of 141 mohs-micrographic surgery providers in Florida.

See all mohs-micrographic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$382,388
Medicare patients
432
Services billed
2,149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil53$2,996
Ketoconazole32$634
Doxycycline Hyclate28$181
Triamcinolone Acetonide24$179
Mupirocin20$130
Ciprofloxacin Hcl14$87
Cefadroxil14$76

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →